The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
CD56 in the Immune System: More Than a Marker for Cytotoxicity?
Open accessAbstract
Over the past years, the phenotypic and functional boundaries distinguishing the main cell subsets of the immune system have become increasingly blurred. In this respect, CD56 (also known as NCAM) is a very good example. CD56 is the archetypal phenotypic marker of natural killers cells, but can actually be expressed by many more immune cells, including alpha beta (αβ) T cells, gamma delta (γδ) T cells, dendritic cells and monocytes. Common to all these CD56-expressing cell types are strong immunostimulatory effector functions, including T helper 1 cytokine production and an efficient cytotoxic capacity. Interestingly, both numerical and functional deficiencies and phenotypic alterations of the CD56+ immune cell fraction have been reported in patients with various infectious, autoimmune or malignant diseases. In this review, we will discuss our current knowledge on the expression and function of CD56 in the hematopoietic system, both in health and disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome Regulation by Long Noncoding RNAs
Rinn, J. L., & Chang, H. Y. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-051410-092902 · Cited by 4,005
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
The biology of innate lymphoid cells
Artis, D., & Spits, H. (2015) · Nature · doi:10.1038/nature14189 · Cited by 1,634
Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
Long, E. O., Sik Kim, H., Liu, D., Peterson, M. E., & Rajagopalan, S. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075005 · Cited by 1,217
Maness, P. F., & Schachner, M. (2007) · Nature Neuroscience · doi:10.1038/nn1827 · Cited by 847
NK cell-based immunotherapy for malignant diseases
Cheng, M., Chen, Y., Xiao, W., Sun, R., & Tian, Z. (2013) · Cellular & Molecular Immunology · doi:10.1038/cmi.2013.10 · Cited by 631
ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming
Segura, E., Nicco, C., Lombard, B., Véron, P., Raposo, G., Batteux, F., Amigorena, S., & Théry, C. (2005) · Blood · doi:10.1182/blood-2005-01-0220 · Cited by 613
Mavilio, D., Lombardo, G., Benjamin, J., Kim, D., Follman, D., Marcenaro, E., O'Shea, M. A., Kinter, A., Kovacs, C., Moretta, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409872102 · Cited by 544
Björkström, N. K., Lindgren, T., Stoltz, M., Fauriat, C., Braun, M., Evander, M., Michaëlsson, J., Malmberg, K.-J., Klingström, J., Ahlm, C., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100762 · Cited by 479
Immune Surveillance Properties of Human NK Cell-Derived Exosomes
Lugini, L., Cecchetti, S., Huber, V., Luciani, F., Macchia, G., Spadaro, F., Paris, L., Abalsamo, L., Colone, M., Molinari, A., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101988 · Cited by 453
PD-1 Blockade Expands Intratumoral Memory T Cells
Ribas, A., Shin, D. S., Zaretsky, J., Frederiksen, J., Cornish, A., Avramis, E., Seja, E., Kivork, C., Siebert, J., Kaplan-Lefko, P., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0210 · Cited by 405 · cited 2×
“For example, in metastatic melanoma, a distinct population of T cells with high expression of HLA-DR and CD56 increased by ninefold in patients responding to anti-PD-1 therapy (15).”
BackgroundSuccessful and Maladaptive T Cell Aging
Goronzy, J. J., & Weyand, C. M. (2017) · Immunity · doi:10.1016/j.immuni.2017.03.010 · Cited by 362
The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
Rezvani, K., & Rouce, R. H. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00578 · Cited by 272
Della Chiesa, M., Falco, M., Podestà, M., Locatelli, F., Moretta, L., Frassoni, F., & Moretta, A. (2012) · Blood · doi:10.1182/blood-2011-08-372003 · Cited by 254
Pittet, M. J., Speiser, D. E., Valmori, D., Cerottini, J.-C., & Romero, P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1148 · Cited by 252
CD56 negative NK cells: origin, function, and role in chronic viral disease
Björkström, N. K., Ljunggren, H.-G., & Sandberg, J. K. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.08.003 · Cited by 250
Reiners, K. S., Topolar, D., Henke, A., Simhadri, V. R., Kessler, J., Sauer, M., Bessler, M., Hansen, H. P., Tawadros, S., Herling, M., et al. (2013) · Blood · doi:10.1182/blood-2013-01-476606 · Cited by 239
Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials
Van Acker, H. H., Anguille, S., Willemen, Y., Smits, E. L., & Van Tendeloo, V. F. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.008 · Cited by 206
Self-citationKusmartsev, S., & Gabrilovich, D. I. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9002-6 · Cited by 183
NCAM‐induced intracellular signaling revisited
Ditlevsen, D. K., Povlsen, G. K., Berezin, V., & Bock, E. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21551 · Cited by 166
Richter, J., Neparidze, N., Zhang, L., Nair, S., Monesmith, T., Sundaram, R., Miesowicz, F., Dhodapkar, K. M., & Dhodapkar, M. V. (2013) · Blood · doi:10.1182/blood-2012-06-435503 · Cited by 164
Alexander, A. A. Z., Maniar, A., Cummings, J.-S., Hebbeler, A. M., Schulze, D. H., Gastman, B. R., Pauza, C. D., Strome, S. E., & Chapoval, A. I. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4912 · Cited by 162
Mesiano, G., Todorovic, M., Gammaitoni, L., Leuci, V., Giraudo, L., Carnevale‐Schianca, F., Fagioli, F., Piacibello, W., Aglietta, M., & Sangiolo, D. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.675323 · Cited by 139
Distinct subpopulations of γδ T cells are present in normal and tumor-bearing human liver
Kenna, T., Golden‐Mason, L., Norris, S., Hegarty, J. E., O’Farrelly, C., & Doherty, D. G. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.05.003 · Cited by 138
Acker, H. H. V., Anguille, S., Willemen, Y., den Bergh, J. M. J. V., Berneman, Z. N., Lion, E., Smits, E., & Tendeloo, V. F. V. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0329-3 · Cited by 133
Self-citationIncreased subpopulations of CD16+ and CD56+ blood monocytes in patients with active Crohnʼs disease
Grip, O., Bredberg, A. C. A., Lindgren, S. C., & Henriksson, G. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20025 · Cited by 130
Effect of age and CMV on NK cell subpopulations
Campos, C., Pera, A., Sanchez-Correa, B., Alonso, C., Lopez-Fernandez, I., Morgado, S., Tarazona, R., & Solana, R. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.01.008 · Cited by 128
Convergence of Innate and Adaptive Immunity during Human Aging
Pereira, B. I., & Akbar, A. N. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00445 · Cited by 126
The IL-12 Signature: NK Cell Terminal CD56+high Stage and Effector Functions
Loza, M. J., & PERUSSIA, B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.88 · Cited by 114
Paul, S., & Lal, G. (2016) · International Journal of Cancer · doi:10.1002/ijc.30109 · Cited by 113
Diversity of γδ T-cell antigens
Born, W. K., Aydintug, M. K., & O’Brien, R. L. (2012) · Cellular and Molecular Immunology · doi:10.1038/cmi.2012.45 · Cited by 111
Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities
Tel, J., Smits, E., Anguille, S., Joshi, R. N., Figdor, C. G., & de Vries, I. J. M. (2012) · Blood · doi:10.1182/blood-2012-06-435941 · Cited by 111
Self-citationLiu, Y., Wu, H.-W., Sheard, M. A., Sposto, R., Somanchi, S. S., Cooper, L. J. N., Lee, D. A., & Seeger, R. C. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1243 · Cited by 110
Papewalis, C., Jacobs, B., Wuttke, M., Ullrich, E., Baehring, T., Fenk, R. R., Willenberg, H. S., Schinner, S., Cohnen, M., Seißler, J., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1462 · Cited by 110
Kelly-Rogers, J., Madrigal-Estebas, L., O’Connor, T., & Doherty, D. G. (2006) · Human Immunology · doi:10.1016/j.humimm.2006.08.292 · Cited by 107
Correia, M. P., da Costa, A. V., Uhrberg, M., Cardoso, E. M., & Arosa, F. A. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.09.012 · Cited by 100
Insights into the Relationship between Toll Like Receptors and Gamma Delta T Cell Responses
Dar, A. A., Patil, R. S., & Chiplunkar, S. V. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00366 · Cited by 94
Cytotoxic NKG2C+ CD4 T Cells Target Oligodendrocytes in Multiple Sclerosis
Zaguia, F., Saikali, P., Ludwin, S. K., Newcombe, J., Beauseigle, D., McCrea, E., Duquette, P., Prat, A., Antel, J. P., & Arbour, N. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202725 · Cited by 93
A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo
Guia, S., Cognet, C., de Beaucoudrey, L., Tessmer, M. S., Jouanguy, E., Berger, C., Filipe‐Santos, O., Feinberg, J. M., Çamcıoğlu, Y., Levy, J., et al. (2008) · Blood · doi:10.1182/blood-2007-11-122259 · Cited by 89
Krasselt, M., Baerwald, C., Wagner, U. G., & Rossol, M. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4321 · Cited by 88
Socinski, M. A., Kaye, F. J., Spigel, D. R., Kudrik, F. J., Ponce, S., Ellis, P. M., Majem, M., Lorigan, P. C., Gandhi, L., Gutierrez, M. E., et al. (2016) · Clinical Lung Cancer · doi:10.1016/j.cllc.2016.09.002 · Cited by 87
Golden‐Mason, L., Kelly, A. M., Doherty, D. G., Traynor, O., McEntee, G., KELLY, J., Hegarty, J. E., & O’Farrelly, C. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02586.x · Cited by 80
Chronic Inflammation and γδ T Cells
Fay, N. S., Larson, E. C., & Jameson, J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00210 · Cited by 80
Targets in small cell lung cancer
Teicher, B. A. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.09.014 · Cited by 79
Interleukin-15 in the treatment of cancer
Waldmann, T. A. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.973856 · Cited by 78
In vivo expansion and activation of γδ T cells as immunotherapy for refractory neuroblastoma
Pressey, J. G., Adams, J. M., Harkins, L. E., Kelly, D. R., You, Z., & Lamb, L. S. (2016) · Medicine · doi:10.1097/md.0000000000004909 · Cited by 77
Human NK cell development requires CD56-mediated motility and formation of the developmental synapse
Mace, E. M., Gunesch, J. T., Dixon, A. L., & Orange, J. S. (2016) · Nature Communications · doi:10.1038/ncomms12171 · Cited by 76
Gruenbacher, G., Gander, H., Nussbaumer, O., Nußbaumer, W., Rahm, A., & Thurnher, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1968 · Cited by 75
Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy
Acker, H. H. V., Anguille, S., Tendeloo, V. F. V., & Lion, E. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1021538 · Cited by 73
Boyiadzis, M. M., Memon, S. A., Carson, J. M., Allen, K., Szczepański, M. J., Vance, B. A., Dean, R. M., Bishop, M., Gress, R. E., & Hakim, F. T. (2008) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2007.12.490 · Cited by 72
Type 1 Innate Lymphoid Cell Biology: Lessons Learnt from Natural Killer Cells
Jiao, Y.-H., Huntington, N., Belz, G., & Seillet, C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00426 · Cited by 72
Chan, W. K., Rujkijyanont, P., Neale, G. A. M., Yang, J., Bari, R., Gupta, N., Holladay, M. S., Rooney, B., & Leung, W. H. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300111 · Cited by 69
Koreck, A., Surányi, A., Szóny, B. J., Farkas, Á., Bata‐Csörgõ, Z., Kemény, L. V., & DOBOZY, A. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01721.x · Cited by 65
Expression of CD56 and WT1 in Ovarian Stroma and Ovarian Stromal Tumors
He, H., Luthringer, D., Hui, P., Lau, S. K., Weiss, L. M., & Chu, P. G. (2008) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181609d59 · Cited by 64
Anguille, S., Acker, H. H. V., den Bergh, J. V., Willemen, Y., Goossens, H., Tendeloo, V. F. V., Smits, E., Berneman, Z. N., & Lion, E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123340 · Cited by 62
Self-citationNatural killer cell subsets in man and rodents.
Inngjerdingen, M., Kveberg, L., Naper, C., & Vaage, J. T. (2011) · Tissue Antigens · doi:10.1111/j.1399-0039.2011.01714.x · Cited by 59
Bontkes, H. J., Kramer, D., Ruizendaal, J. J., Meijer, C. J. L. M., & Hooijberg, E. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.02.001 · Cited by 58
Almeida, I., Silva, S. V., Fonseca, A. R., Silva, I., Vasconcelos, C., & Lima, M. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8505-8 · Cited by 56
Anguille, S., Lion, E., Tel, J., de Vries, I. J. M., Couderé, K., Fromm, P. D., Tendeloo, V. F. V., Smits, E., & Berneman, Z. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051851 · Cited by 56
Self-citationNo monkey business: why studying NK cells in non-human primates pays off
Hong, H., Rajakumar, P., Billingsley, J. M., Reeves, R., & Johnson, R. (2012) · Front. Immun. · doi:10.3389/fimmu.2013.00032 · Cited by 52
Tang, Q., Grzywacz, B. J., Wang, H., Kataria, N., Cao, Q., Wagner, J. E., Blazar, B. R., Miller, J. S., & Verneris, M. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4507 · Cited by 51
Gruenbacher, G., Nussbaumer, O., Gander, H., Steiner, B., Leonhartsberger, N., & Thurnher, M. (2014) · OncoImmunology · doi:10.4161/21624011.2014.953410 · Cited by 50
Allan, D., Cerdeira, A. S., Ranjan, A., Kirkham, C. L., Aguilar, O. A., Tanaka, M., Childs, R. W., Dunbar, C. E., Strominger, J. L., Kopcow, H. D., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03256-0 · Cited by 47
CD56+ human blood dendritic cells effectively promote TH1-type γδ T-cell responses
Gruenbacher, G., Gander, H., Rahm, A., Nußbaumer, W., Romani, N., & Thurnher, M. (2009) · Blood · doi:10.1182/blood-2009-06-227256 · Cited by 43
García‐Cuesta, E. M., Esteso, G., Ashiru, O., López‐Cobo, S., Álvarez‐Maestro, M., Linares, A., Ho, M. M., Martínez‐Piñeiro, L., Reyburn, H. T., & Valés‐Gómez, M. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1293212 · Cited by 43
Skog, M. S., Nystedt, J. M., Korhonen, M. O., Anderson, H., Lehti, T. A., Pajunen, M. I., & Finne, J. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0373-5 · Cited by 39
Fujii, C., Kondo, T., Ochi, H., Okada, Y., Hashi, Y., Adachi, T., Shin‐Ya, M., Matsumoto, S., Takahashi, R., Nakagawa, M., et al. (2016) · Scientific Reports · doi:10.1038/srep35314 · Cited by 37
Li, X., Peng, J., Pang, Y., Yu, S., Yu, X., Chen, P., Wang, W., Han, W., Zhang, J., Yin, Y., et al. (2015) · Scientific Reports · doi:10.1038/srep14757 · Cited by 35
CD56 Marks an Effector T Cell Subset in the Human Intestine
Cohavy, O., & Targan, S. R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5524 · Cited by 34
Spallanzani, R. G., Torres, N. I., Avila, D. E., Ziblat, A., Iraolagoitia, X. L. R., Rossi, L. E., Domaica, C. I., Fuertes, M. B., Rabinovich, G. A., & Zwirner, N. W. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403161 · Cited by 33
Hasumi, K., Aoki, Y., Wantanabe, R., & Mann, D. L. (2013) · OncoImmunology · doi:10.4161/onci.26381 · Cited by 32
Lu, X., Kondo, Y., Takamatsu, H., Ohata, K., Yamazaki, H., Takami, A., Akatsuka, Y., & Nakao, S. (2008) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2008.01073.x · Cited by 31
Poonia, B., & Pauza, C. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088884 · Cited by 28
Yin, W., Tong, S., Zhang, Q., shao, J., Liu, Q., Peng, H., Hu, H., Peng, M., Hu, P., Ren, H., et al. (2016) · Scientific Reports · doi:10.1038/srep26296 · Cited by 28
Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral Activity
Jacobson, A. C., Bell, F., Lejarcegui, N., Mitchell, C. M., Frenkel, L. M., & Horton, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067700 · Cited by 24
Contribution of neural cell adhesion molecule (NCAM) to hemopoietic system in monkeys
Kato, J., Hisha, H., Wang, X., Mizokami, T., Okazaki, S., Li, Q., Song, C., Maki, M., Hosaka, N., Adachi, Y., et al. (2008) · Annals of Hematology · doi:10.1007/s00277-008-0513-9 · Cited by 20
Increased numbers of tumor-lysing monocytes in cancer patients
Papewalis, C., Jacobs, B., Baran, A. M., Ehlers, M., Stoecklein, N. H., Willenberg, H. S., Schinner, S., Anlauf, M., Raffel, A., Cupisti, K., et al. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.01.020 · Cited by 20
Murday, A., Chaudhry, S., & Pauza, C. D. (2017) · Immunology · doi:10.1111/imm.12735 · Cited by 19
Cited by
Re-epithelialization and immune cell behaviour in an ex vivo human skin model
Rakita, A., Nikolić, N., Mildner, M., Matiasek, J., & Elbe-Bürger, A. (2020) · Scientific Reports · doi:10.1038/s41598-019-56847-4 · Cited by 8,228
Cancer immunotherapy with γδ T cells: many paths ahead of us
Kabelitz, D., Serrano, R., Kouakanou, L., Peters, C., & Kalyan, S. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0504-x · Cited by 294
Zero-preserving imputation of single-cell RNA-seq data
Linderman, G. C., Zhao, J., Roulis, M., Bielecki, P., Flavell, R. A., Nadler, B., & Kluger, Y. (2022) · Nature Communications · doi:10.1038/s41467-021-27729-z · Cited by 275
Normalizing and denoising protein expression data from droplet-based single cell profiling
Mulè, M. P., Martins, A. J., & Tsang, J. S. (2022) · Nature Communications · doi:10.1038/s41467-022-29356-8 · Cited by 197
Waugh, K. A., Araya, P., Pandey, A., Jordan, K. R., Smith, K. P., Granrath, R. E., Khanal, S., Butcher, E. T., Estrada, B. E., Rachubinski, A. L., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.038 · Cited by 150
Metadata
- Authors
- Van Acker, H. H., Capsomidis, A., Smits, E. L., & Van Tendeloo, V. F.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2017-07-24
- Volume
- 8
- Pages
- 892-892
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2735932253
- Cited by
- 388
- References
- 78
- FWCI
- 9.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.